Bilateral adrenal masses and Adrenal insufficiency caused by Primary adrenal lymphoma: A Case Report

Bilateral adrenal masses and Adrenal insufficiency caused by Primary adrenal lymphoma: A Case Report


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: مهسا ملک یان , امیر بهرامی , جلیل هوشیار قراملکی , مرتضی رئیسی , امین صدرآذر , امیر واحدی , حمیدرضا عشایری

عنوان کنگره / همایش: EndoBridge2025 , Turkey , Antalya , 2025

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله مهسا ملک یان
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات غدد درون ریز
کد مقاله 88887
عنوان فارسی مقاله Bilateral adrenal masses and Adrenal insufficiency caused by Primary adrenal lymphoma: A Case Report
عنوان لاتین مقاله Bilateral adrenal masses and Adrenal insufficiency caused by Primary adrenal lymphoma: A Case Report
نوع ارائه سخنرانی
عنوان کنگره / همایش EndoBridge2025
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش Turkey
شهر محل برگزاری کنگره/ همایش Antalya
سال انتشار/ ارائه شمسی 1404
سال انتشار/ارائه میلادی 2025
تاریخ شمسی شروع و خاتمه کنگره/همایش 1404/08/01 الی 1404/08/04
آدرس لینک مقاله/ همایش در شبکه اینترنت https://www.abstractagent.com/av4/readabstract.asp?pdir=2025endobridge&plng=eng&abstract_un=0007
آدرس علمی (Affiliation) نویسنده متقاضی Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
مهسا ملک یاناول
امیر بهرامیدوم
جلیل هوشیار قراملکیسوم
مرتضی رئیسیچهارم
امین صدرآذرپنجم
امیر واحدیششم
حمیدرضا عشایریهفتم

اطلاعات تفضیلی
hide/show

عنوان متن
خلاصه مقالهBackground: Primary adrenal lymphoma (PAL) usually presents as a bilateral heterogeneous adrenal mass on computed tomography (CT). PAL is a rare type of lymphoma originating from adrenal tissue and causes adrenal insufficiency (AI). We present a case of PAL with the complaint of loss of appetite and signs of AI. Case presentation: A 75-year-old male with symptoms of weight loss (approximately 10 kg ), nausea and vomiting over 4 weeks was referred to the endocrin clinic with the possibility of AI. On physical exam, the patient had slightly dark skin and had hypotension (BP: 90/55). The lab tests revealed hypekalemia (K+: 5.1 mEq/L), near-normal sodium levels (Na+: 135 mEq/L), and high ferritin levels (ferritin: 791 ng/dL, normal range: 17-327) high LDH levels( 420 U/L ,NL: 135-225 U/L) The hormonal evaluation of patients confirmed AI due to low cortisol (Cortisol: 3µg/dL, normal level: 5-25 µg/dL) and high ACTH (ACTH: 2135 pg/dL, normal range: 4.7-48.8 pg/dL). In compound tomography (Figure 1), the patient had bilateral adrenal masses of 58*54mm and 58*48mm on the right and left adrenal , with no lymphadenopathy. To evaluate the nature of the mass, an adrenal biopsy was performed, which reported a malignant neoplasm. The IHC study was positive for CD45 with a Ki-65 level of approximately 80%. The IHC study was in favor of high-grade lymphoma. The patient was given 0.1 mg of fludrocortisone and 20 mg of hydrocortisone daily for AI and then was referred to the oncology ward for chemotherapy and, unfortunately, died before the start of chemotherapy. Conclusion: Adrenal lymphoma can be divided into two categories: primary and secondary adrenal lymphoma. Secondary adrenal lymphoma is the most prevalent type of adrenal lymphoma. PAL is usually seen in the elderly male population and causes a bilateral adrenal mass. PAL causes AI due to the cytokines released from immune cells, rather than the mass effect. The exact pathophysiology of PAL is unknown, and the most common reported subtype of PAL is DLBCL lymphoma, but other subtypes, such as peripheral T-cell lymphoma and Burkitt`s lymphoma, are also reported. The prognosis of PAL is poor and is associated with high mortality rates. Currently, there are no specific biomarkers for PAL, but studies suggest high LDH and ferritin levels in PAL. Adrenal biopsy is needed to confirm the diagnosis of PAL and determine the exact subtype of PAL. Some of the important markers for PAL are CD45, Ki-67 level, CD10, CD20, MUM1, BCL2, and BCL6. The preferred treatment for PAL is the R-CHOP chemotherapy regimen with a 2-year overall survival rate of 57%.
کلمات کلیدیBilateral adrenal mass ،Adrenal insufficiency ،Primary adrenal lymphoma،Case Report

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
2025endobridge179935414.pdf1404/08/16179970دانلود
PHOTO-2025-11-07-19-28-57.jpg1404/08/1669320دانلود
Manuscript.pdf1404/08/24536190دانلود
Bilateral adrenal masses and Adrenal insufficiency caused by.pptx1404/08/241127184دانلود